American Medical Centers Tbilisi is excited to introduce a liquid based cytology for Cervical Cancer Screening.
Cervical cancer is one of the most common female malignancies worldwide. Since the introduction of the conventional PAP-test, mortality from cervical cancer has reduced considerably. But despite its success, it has sensitivity of only 51% and a false negative rate of 5-10% while Liquid Based Cytology (LBC) is the newest and the most sensitive approach in detecting cervical abnormalities.
The Pap Test uses a small spatula to gather the cell sample, which is then ‘smeared’ onto a slide for examination. Liquid Based Cytology replaces the spatula with a small brush, and deposits the collected cells in a preservative fluid in a small container. It allows the laboratory to separate out mucus and blood before the cells are deposited onto the slide, which makes the test much more accurate.
Today, LBC accounts for over 90% of the Pap tests performed in the United States.
In Addition to assessing LBC we are also evaluating Bacterial flora of cervix including all Sexually Transmitted Diseases, Human Papilloma Viruses and more…
DNA Lactobacillus spp.
DNA Gardnerella vaginalis
DNA Atopobium vaginae
DNA Staphylococcus spp.
DNA Streptococcus spp.
|Sexually – Transmitted Infections (STIs)
|Presence of Fungi or Genus Candida
DNA Candida krusei
DNA Candida albicans
DNA Candida glabrata
DNA Candida tropicalis
DNA Candida parapsilosis
DNA Ureaplasma parvum
DNA Mycoplasma hominis
DNA Ureaplasma urealyticum
|Human Papillomavirus of High Oncogenic Risk
DNA Phylogenetic group A9 (Types: 16, 31, 33, 35, 52, 58)
DNA Phylogenetic group A5/A6 (Types: 51, 56)
DNA Phylogenetic group A7 (Types: 18, 39, 45, 59)
Price – $375